Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» colorectal cancer
colorectal cancer
Phase 3 Trial Comparing Vectibix® (Panitumumab) to Erbitux® (Cetuximab) Meets Primary Endpoint Of Non-Inferiority Of Overall Survival
Yahoo/PR NewsWire
Sat, 09/28/13 - 11:56 am
Vectibix
colorectal cancer
Amgen
FDA approves Teva's generic version of Roche cancer drug Xeloda
Reuters
Mon, 09/16/13 - 03:46 pm
generics
Teva
FDA
Roche
Xeloda
breast cancer
colorectal cancer
Amgen, Zhejiang Beta Pharma form JV to commercialise Vectibix in Chinese market
Pharmabiz
Sun, 05/12/13 - 11:00 am
Beta Pharma
Vectibix
Amgen
colorectal cancer
Exact Sciences cancer test meets goal, but disappoints investors
Reuters
Thu, 04/18/13 - 08:03 am
EXACT Sciences
colorectal cancer
Immunomedics Reports First Results of Labetuzumab-SN-38 in Colorectal Cancer
Yahoo
Tue, 04/9/13 - 10:27 am
colorectal cancer
Immunomedics
labetuzumab-SN-38
Amgen's Neulasta Succeeds in Phase 3 Cancer Trial
Motley Fool
Mon, 01/28/13 - 12:29 pm
Amgen
Neulasta
colorectal cancer
Amgen Announces Results From Phase 3 PAVES Study Evaluating Neulasta In Patients With Colorectal Cancer
Yahoo/PR Newswire
Sat, 01/26/13 - 11:52 am
Amgen
Neulasta
colorectal cancer
colon cancer
FDA approves new use for Roche's Avastin in colon cancer treatment
Reuters
Thu, 01/24/13 - 10:40 am
Roche
FDA
Avastin
colorectal cancer
Epigenomics AG Vs. Exact Sciences: Who Wins The CRC Early Detection Fight?
Seeking Alpha
Wed, 01/16/13 - 11:10 am
Epigenomics AG
EXACT Sciences
colorectal cancer
Latest Tivantinib Failure Hits ArQule Despite Its Irrelevance
Seeking Alpha
Tue, 01/15/13 - 11:39 am
tivantinib
Arqule
colorectal cancer
Daiichi Sankyo
Sanofi Wins EU Backing for Drugs Against Diabetes, Cancer
Bloomberg
Sat, 11/17/12 - 01:42 pm
Lyxumia
diabetes
Zaltrap
colorectal cancer
Sanofi Wins EU Backing for New Drugs Against Diabetes and Cancer
Bloomberg
Fri, 11/16/12 - 10:43 am
Sanofi
Europe
diabetes
Zaltrap
colorectal cancer
Lyxumia
Bayer, Onyx Win U.S. Approval for Colorectal Cancer Treatment
Bloomberg
Thu, 09/27/12 - 11:26 am
colorectal cancer
Bayer
ONYX Pharmaceuticals
FDA
regorafenib
Why Regeneron May Not Profit Much From Today's FDA Approval
Forbes
Sat, 08/4/12 - 12:07 pm
Regeneron
Zaltrap
colorectal cancer
Spectrum Pharmaceuticals: Bears Beware, Fusilev Strength Points To Strong Second Quarter
Seeking Alpha
Sun, 07/15/12 - 12:25 pm
Fusilev
Spectrum Pharmaceuticals
colorectal cancer
colon cancer
Bristol-Myers Gets U.S. Approval For Wider Erbitux Use
Bloomberg
Fri, 07/6/12 - 07:21 pm
Bristol-Myers Squibb
colorectal cancer
Eli Lilly
Erbitux
Priority Review for Bayer/Onyx
Yahoo/Zacks
Sat, 06/30/12 - 12:52 pm
Bayer
ONYX Pharmaceuticals
regorafenib
colorectal cancer
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
ASCO
Genentech
T-DM1
breast cancer
tivozanib
Aveo
kidney cancer
Onyx
Bayer
regorafenib
colorectal cancer
Adcetris
Seattle Genetics
JNJ
prostate cancer
Zytiga
cabozantinib
Exelixis
Enzalutamide
Medivation
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
Spectrum: Increased Fusilev Production May Boost Stock
Seeking Alpha
Mon, 04/30/12 - 10:17 am
Spectrum
Fusilev
Abbott Laboratories
AstraZeneca
colorectal cancer
GSK
Biogen Idec
Eli Lilly
Priority Review for Zaltrap
Yahoo/Zacks
Thu, 04/5/12 - 09:12 pm
Zaltrap
Regeneron
Sanofi
colorectal cancer
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »